BackGo to journal finder

Antibodies

eISSN: 2073-4468pISSN: 2073-4468
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Request a quick quote

Key Metrics

2
Time to Publish
time-to-publish View Chart
2  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    Multidisciplinary Digital Publishing Institute (MDPI)
  • Language
    English
  • Frequency
    Quarterly
  • Article Processing Charges
    CHF 1600
  • Publication Time
    6
  • Editorial Review Process
    Blind peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 80%
4-6 19%
7-9 0%
>9 1%

Topics Covered

Monoclonal antibody
Breast cancer
Antibody-drug conjugate
Tumor microenvironment
Inherited epidermolysis bullosa
Effector functions
Severe acute respiratory syndrome coronavirus
Trastuzumab
Polyclonal antibodies
Core protein
Epidermolysis bullosa
Clinical trial
Lymphatic filariasis
Complement system
Complement-dependent cytotoxicity
Pathological Angiogenesis
Spike Protein
Antigen
Drug discovery
Filarial parasite

Recently Published Papers

View all papers for this journal

Year-wise Publication

  • 5Y
  • 10Y

FAQs

Since when has Antibodies been publishing? Faqs

The Antibodies has been publishing since 2012 till date.

How frequently is the Antibodies published? Faqs

Antibodies is published Quarterly.

Who is the publisher of Antibodies? Faqs

The publisher of Antibodies is Multidisciplinary Digital Publishing Institute (MDPI).

How can I view the journal metrics of Antibodies on editage? Faqs

For the Antibodies metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Antibodies? Faqs

The eISSN number is 2073-4468 and pISSN number is 2073-4468 for Antibodies.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Monoclonal antibody, Breast cancer, Antibody-drug conjugate, Tumor microenvironment, Inherited epidermolysis bullosa, Effector functions, Severe acute respiratory syndrome coronavirus, Trastuzumab, Polyclonal antibodies, Core protein, Epidermolysis bullosa, Clinical trial, Lymphatic filariasis, Complement system, Complement-dependent cytotoxicity, Pathological Angiogenesis, Spike Protein, Antigen, Drug discovery, Filarial parasite.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.

Global Journal Library: